Form 4: Humana Director Gordon Smith Acquires Restricted Stock Units

Humana director Gordon Smith received 765 restricted stock units as part of the annual Director Compensation Program.

Summary

• On November 1, 2024, Humana director Gordon Smith acquired 765 shares of Humana common stock in the form of restricted stock units.
• The acquisition was part of the annual Director Compensation Program and valued at $200,000.
• The restricted stock units represent a contingent right to receive one share of Humana Inc. common stock each, under the company's 2019 Amended & Restated Stock Incentive Plan.
• The award will be forfeited if service is less than one year.

Sentiment

Score: 7

Explanation: The document reflects a routine director compensation event, which is generally viewed neutrally to positively as it aligns director interests with shareholders.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting period encourages continued service and commitment to the company.

Risks

• The award is subject to forfeiture if service is less than one year, which could be a risk if the director leaves the company before the vesting period.

Industry Context

Director compensation packages often include restricted stock units to align the interests of directors with those of shareholders and to incentivize long-term commitment to the company's success.

Comparison to Industry Standards

• Director compensation packages vary across the healthcare industry, but restricted stock units are a common component.
• Companies like UnitedHealth Group and CVS Health also utilize equity-based compensation for their directors.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates